• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌的流行病学和危险因素的新知识和旧知识。

New and old knowledge on differentiated thyroid cancer epidemiology and risk factors.

机构信息

Department of Endocrinology, University of Pisa, Via Paradisa 2, Pisa, Italy.

出版信息

J Endocrinol Invest. 2012;35(6 Suppl):3-9.

PMID:23014067
Abstract

Differentiated thyroid cancer (DTC) represents 1-2% of all human malignancies. The annual incidence varies among countries and it is estimated that 1.2-2.6 men and 2.0-3.8 women/100,000 individuals are affected worldwide. This incidence has been increasing in the last decades, likely due to an "over-diagnosis" of small cancers that would have remained occult and that have been likely revealed because of an increased diagnostic scrutiny rather than a real increase of incidence. The annual mortality rate for DTC is 0.5/100,000 both in men and women. DTC is 2-4 times more frequent in females than in males. The mean age at diagnosis is 40-45 yr for papillary tumors (PTC) and 50-55 yr for follicular tumors (FTC). They are very rare in children. Ninety percent of DTC are represented by PTC hystotype, mainly follicular and classical variants. In the last years it has been observed an important change in the oncogenic pattern of PTC with a significant reduction of RET/PTC rearrangements and an increase of BRAFV600E mutation suggesting a change in pathogenic events. The unique well-demonstrated risk factor of DTC is the exposure to external radiation which is also correlated with the presence of RET/PTC rearrangements. Recently, other environmental factors (i.e. living in a volcanic area or in a iodine- either deficient or rich area) or some eating habits leading to obesity have been considered as potential DTC risk factors. However, at present, the favorite hypothesis is that a complex interaction between genetic and environmental factors is required to develop DTC.

摘要

分化型甲状腺癌(DTC)占人类恶性肿瘤的 1-2%。其发病率在各国之间存在差异,据估计,全世界每年有 1.2-2.6 名男性和 2.0-3.8 名女性/10 万人受到影响。在过去几十年中,这种发病率一直在增加,这可能是由于对原本隐匿且可能因诊断检查增加而被发现的小癌症的“过度诊断”所致,而不是发病率的真正增加。DTC 的年死亡率在男性和女性中均为 0.5/10 万。DTC 在女性中的发病率是男性的 2-4 倍。乳头状癌(PTC)和滤泡状癌(FTC)的平均诊断年龄分别为 40-45 岁和 50-55 岁。它们在儿童中非常罕见。90%的 DTC 是由 PTC 组织学类型代表,主要是滤泡状和经典型。近年来,PTC 的致癌模式发生了重要变化,RET/PTC 重排明显减少,BRAFV600E 突变增加,提示发病机制发生了变化。DTC 唯一明确的危险因素是暴露于外源性辐射,这也与 RET/PTC 重排的存在相关。最近,其他环境因素(如生活在火山地区或碘缺乏或丰富的地区)或一些导致肥胖的饮食习惯也被认为是潜在的 DTC 危险因素。然而,目前,人们普遍认为,遗传和环境因素之间的复杂相互作用是导致 DTC 发生的必要条件。

相似文献

1
New and old knowledge on differentiated thyroid cancer epidemiology and risk factors.分化型甲状腺癌的流行病学和危险因素的新知识和旧知识。
J Endocrinol Invest. 2012;35(6 Suppl):3-9.
2
Primary surgery for differentiated thyroid cancer in the new millennium.新世纪分化型甲状腺癌的初次手术治疗。
J Endocrinol Invest. 2012;35(6 Suppl):10-5.
3
Radiation induced thyroid cancer: fundamental and applied aspects.辐射诱发的甲状腺癌:基础与应用方面
Exp Oncol. 2010 Sep;32(3):200-4.
4
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.BRAFV600E突变而非RET/PTC重排与甲状腺乳头状癌中甲状腺过氧化物酶和钠碘同向转运体基因的低表达相关。
Endocr Relat Cancer. 2008 Jun;15(2):511-20. doi: 10.1677/ERC-07-0130.
5
Thyroid malignancies: a New Zealand South Island thyroid clinic experience 1995-2006.甲状腺恶性肿瘤:1995 - 2006年新西兰南岛甲状腺诊所的经验
N Z Med J. 2008 Aug 8;121(1279):36-45.
6
Papillary thyroid cancer incidence in the volcanic area of Sicily.西西里岛火山地区的甲状腺乳头状癌发病率。
J Natl Cancer Inst. 2009 Nov 18;101(22):1575-83. doi: 10.1093/jnci/djp354. Epub 2009 Nov 5.
7
The epidemiology and etiology of differentiated thyroid carcinoma.分化型甲状腺癌的流行病学与病因学
Biomed Pharmacother. 2000 Jul;54(6):322-6. doi: 10.1016/S0753-3322(00)80056-6.
8
Global variation in the pattern of differentiated thyroid cancer.全球分化型甲状腺癌的模式变化。
Am J Surg. 2010 Oct;200(4):462-6. doi: 10.1016/j.amjsurg.2010.03.009.
9
Radiation carcinogenesis: lessons from Chernobyl.辐射致癌:切尔诺贝利的教训。
Oncogene. 2008 Dec;27 Suppl 2:S9-18. doi: 10.1038/onc.2009.349.
10
The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.塔斯马尼亚岛甲状腺癌发病率和谱在从碘充足向碘缺乏转变期间(1978 - 1998年)的变化
J Clin Endocrinol Metab. 2000 Apr;85(4):1513-7. doi: 10.1210/jcem.85.4.6554.

引用本文的文献

1
A bibliometric analysis of inflammation and thyroid carcinoma: research trends and future perspectives.炎症与甲状腺癌的文献计量分析:研究趋势与未来展望
Front Oncol. 2025 Aug 1;15:1593006. doi: 10.3389/fonc.2025.1593006. eCollection 2025.
2
Global trend and disparity in the burden of thyroid cancer attributable to high body-mass index from 1990 to 2021 and projection to 2049: a systematic analysis based on the Global Burden of Disease Study 2021.1990年至2021年及到2049年预测期间,全球因高体重指数导致的甲状腺癌负担的趋势和差异:基于《2021年全球疾病负担研究》的系统分析
BMC Public Health. 2025 Mar 18;25(1):1051. doi: 10.1186/s12889-025-21960-9.
3
Comprehensive Gene Expression Analysis in Papillary Thyroid Carcinoma Reveals a Transcriptional Profile Associated with Reduced Radioiodine Avidity.
甲状腺乳头状癌的综合基因表达分析揭示了与放射性碘摄取减少相关的转录谱。
Endocr Pathol. 2025 Feb 21;36(1):4. doi: 10.1007/s12022-025-09849-0.
4
Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.沉默调节蛋白 4 水平降低促进甲状腺乳头状癌的细胞增殖和侵袭。
Eur Thyroid J. 2024 Sep 16;13(5). doi: 10.1530/ETJ-24-0079. Print 2024 Oct 1.
5
Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes.分化型甲状腺癌伴肥胖和糖尿病的临床特征及治疗反应。
BMC Cancer. 2023 Nov 8;23(1):1077. doi: 10.1186/s12885-023-11591-x.
6
Obesity and Thyroid Cancer Risk: An Update.肥胖与甲状腺癌风险:更新。
Int J Environ Res Public Health. 2022 Jan 20;19(3):1116. doi: 10.3390/ijerph19031116.
7
Epidemiology of Thyroid Carcinomas in North Macedonia (1999-2015).北马其顿甲状腺癌的流行病学(1999-2015 年)。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211004286. doi: 10.1177/21501327211004286.
8
BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.BGL3 通过调控 PTEN 稳定性抑制甲状腺乳头状癌细胞的进展。
J Endocrinol Invest. 2021 Oct;44(10):2165-2174. doi: 10.1007/s40618-021-01519-2. Epub 2021 Feb 4.
9
Incidence of the Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.甲状腺乳头状癌患者胚系突变的发生率及其对临床病理特征、治疗反应和疾病进程的影响。
Cancers (Basel). 2021 Jan 26;13(3):470. doi: 10.3390/cancers13030470.
10
Does every classical type of well-differentiated thyroid cancer have excellent prognosis? A case series and literature review.每种经典类型的高分化甲状腺癌预后都良好吗?一项病例系列研究及文献综述。
Cancer Manag Res. 2019 Apr 1;11:2441-2448. doi: 10.2147/CMAR.S198514. eCollection 2019.